• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类微生物组作为个性化医疗的一种途径。

Human Microbiome as an Approach to Personalized Medicine.

作者信息

Ejtahed Hanieh-Sadat, Hasani-Ranjbar Shirin, Larijani Bagher

出版信息

Altern Ther Health Med. 2017 Nov;23(6):8-9.

PMID:28987073
Abstract

Personalized medicine is an approach for medical decisions, practices, and interventions that considers individual variations in genes, environment, and lifestyle for each person. Regarding complex metabolic patterns associated with different diseases, characterizing unique metabolic patterns of each patient seems like a practical approach. We can imagine a future in which routinely analyzing the microbiome allows us to predict individualized responses to different foods and drugs. Microbiome analysis of individuals may be added to future routine personalized medicine protocols after comparing the costs and benefits of microbiome-sequencing technology. Moreover, improved understanding of the human microbiome could lead to the development of novel therapeutic strategies for different diseases. Potential therapeutic agents, such as personalized probiotic and prebiotic supplements, dietary interventions, and fecal microbiota transplantation that can be used to reshape the gut microbiome, represent a reasonable strategy in an era of personalized medicine.

摘要

个性化医疗是一种用于医疗决策、实践和干预的方法,它考虑了每个人在基因、环境和生活方式方面的个体差异。对于与不同疾病相关的复杂代谢模式,表征每个患者独特的代谢模式似乎是一种切实可行的方法。我们可以设想这样一个未来,即常规分析微生物组能让我们预测个体对不同食物和药物的反应。在比较微生物组测序技术的成本和效益之后,个体的微生物组分析可能会被纳入未来的常规个性化医疗方案中。此外,对人类微生物组的深入了解可能会促成针对不同疾病的新型治疗策略的开发。潜在的治疗剂,如可用于重塑肠道微生物组的个性化益生菌和益生元补充剂、饮食干预措施以及粪便微生物群移植,在个性化医疗时代是一种合理的策略。

相似文献

1
Human Microbiome as an Approach to Personalized Medicine.人类微生物组作为个性化医疗的一种途径。
Altern Ther Health Med. 2017 Nov;23(6):8-9.
2
Understanding the microbiome: Emerging biomarkers for exploiting the microbiota for personalized medicine against cancer.理解微生物组:利用微生物组开发针对癌症的个体化医学的新兴生物标志物。
Semin Cancer Biol. 2018 Oct;52(Pt 1):1-8. doi: 10.1016/j.semcancer.2018.02.003. Epub 2018 Feb 6.
3
Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics.药物微生物组学:人类微生物组变异对系统药理学和个性化治疗的影响。
OMICS. 2014 Jul;18(7):402-14. doi: 10.1089/omi.2014.0018. Epub 2014 May 2.
4
Dietary Interventions to Modulate the Gut Microbiome-How Far Away Are We From Precision Medicine.饮食干预调节肠道微生物组——我们离精准医学还有多远。
Inflamm Bowel Dis. 2018 Sep 15;24(10):2142-2154. doi: 10.1093/ibd/izy080.
5
Towards utilization of the human genome and microbiome for personalized nutrition.为实现个性化营养,利用人类基因组和微生物组。
Curr Opin Biotechnol. 2018 Jun;51:57-63. doi: 10.1016/j.copbio.2017.11.013. Epub 2017 Dec 7.
6
Clinical Applications of Personalized Medicine: A New Paradigm and Challenge.个性化医疗的临床应用:一种新范式与挑战。
Curr Pharm Biotechnol. 2017;18(3):194-203. doi: 10.2174/1389201018666170224105600.
7
Pharmacomicrobiomics: a novel route towards personalized medicine?药物微生物组学:迈向个体化医学的新途径?
Protein Cell. 2018 May;9(5):432-445. doi: 10.1007/s13238-018-0547-2. Epub 2018 Apr 28.
8
[Personalized medicine and individual healthcare : Medical and information technology aspects].[个性化医疗与个体医疗保健:医学与信息技术方面]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Aug;53(8):776-82. doi: 10.1007/s00103-010-1098-8.
9
Classification of Chronic Rhinosinusitis-Working Toward Personalized Diagnosis.慢性鼻-鼻窦炎的分类——迈向个性化诊断
Otolaryngol Clin North Am. 2017 Feb;50(1):1-12. doi: 10.1016/j.otc.2016.08.003.
10
Personalized microbiome-based approaches to metabolic syndrome management and prevention.基于个性化微生物群的代谢综合征管理与预防方法。
J Diabetes. 2017 Mar;9(3):226-236. doi: 10.1111/1753-0407.12501.

引用本文的文献

1
The Comparison of the Gut Microbiome Composition, Serum Inflammatory Markers and Faecal Short-Chain Fatty Acids Among Individuals With Type 1 and 2 Diabetes Mellitus With Healthy Controls: A Case-Control Study.1型和2型糖尿病患者与健康对照者的肠道微生物群组成、血清炎症标志物和粪便短链脂肪酸比较:一项病例对照研究。
Endocrinol Diabetes Metab. 2025 Jul;8(4):e70071. doi: 10.1002/edm2.70071.
2
Comparison of diet and exercise on cardiometabolic factors in young adults with overweight/obesity: multiomics analysis and gut microbiota prediction, a randomized controlled trial.饮食与运动对超重/肥胖青年人心血管代谢因素的影响比较:多组学分析与肠道微生物群预测,一项随机对照试验
MedComm (2020). 2025 Jan 12;6(1):e70044. doi: 10.1002/mco2.70044. eCollection 2025 Jan.
3
Effectiveness of Probiotics, Prebiotics, and Synbiotics in Managing Insulin Resistance and Hormonal Imbalance in Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review of Randomized Clinical Trials.益生菌、益生元和合生剂在管理多囊卵巢综合征(PCOS)女性胰岛素抵抗和激素失衡中的有效性:随机临床试验的系统评价。
Nutrients. 2024 Nov 16;16(22):3916. doi: 10.3390/nu16223916.
4
The Beneficial Effects of Dietary Interventions on Gut Microbiota-An Up-to-Date Critical Review and Future Perspectives.膳食干预对肠道微生物群的有益影响——最新的批判性综述及未来展望
Nutrients. 2023 Dec 3;15(23):5005. doi: 10.3390/nu15235005.
5
Ethical challenges in conducting and the clinical application of human microbiome research.人类微生物组研究的开展及临床应用中的伦理挑战。
J Med Ethics Hist Med. 2023 Jul 7;16:5. doi: 10.18502/jmehm.v16i5.13313. eCollection 2023.
6
Gut microbiota and transcriptome dynamics in every-other-day fasting are associated with neuroprotection in rats with spinal cord injury.隔日禁食时肠道微生物群和转录组动态变化与脊髓损伤大鼠的神经保护作用相关。
Front Microbiol. 2023 Jul 28;14:1206909. doi: 10.3389/fmicb.2023.1206909. eCollection 2023.
7
Use of dexmedetomidine to alleviate intestinal ischemia-reperfusion injury via intestinal microbiota modulation in mice.使用右美托咪定通过调节小鼠肠道微生物群来减轻肠道缺血再灌注损伤。
Ann Transl Med. 2022 Nov;10(21):1161. doi: 10.21037/atm-22-824.
8
Gut microbiota modulation as a possible mediating mechanism for fasting-induced alleviation of metabolic complications: a systematic review.肠道微生物群调节作为禁食诱导缓解代谢并发症的一种可能介导机制:一项系统综述
Nutr Metab (Lond). 2021 Dec 14;18(1):105. doi: 10.1186/s12986-021-00635-3.
9
Changes in Plasma Choline and the Betaine-to-Choline Ratio in Response to 6-Month Lifestyle Intervention Are Associated with the Changes of Lipid Profiles and Intestinal Microbiota: The ICAAN Study.对胆碱和甜菜碱与胆碱比值的血浆变化的反应对 6 个月生活方式干预与血脂谱和肠道微生物群的变化相关:ICAAN 研究。
Nutrients. 2021 Nov 10;13(11):4006. doi: 10.3390/nu13114006.
10
The promise of the gut microbiome as part of individualized treatment strategies.肠道微生物组作为个体化治疗策略的一部分的前景。
Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):7-25. doi: 10.1038/s41575-021-00499-1. Epub 2021 Aug 27.